Assertio Therapeutics
ASRT
₹55.76
Share price
-3.23%
Change (1 day)
-53.62%
Change (1 year)
Categories
Assertio Therapeutics (ASRT) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : ₹15.19 Billion
According to Assertio Therapeutics 's latest financial reports the company's total liabilities are ₹15.19 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Assertio Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | ₹14.03 B | 13.63% |
| 2023-12-31 | ₹12.35 B | -20.66% |
| 2022-12-31 | ₹15.57 B | -6.65% |
| 2021-12-31 | ₹16.68 B | -7.93% |
| 2020-12-31 | ₹18.11 B | -45.85% |
| 2019-12-31 | ₹33.45 B | -32.84% |
| 2018-12-31 | ₹49.82 B | -10.22% |
| 2017-12-31 | ₹55.49 B | -16.21% |
| 2016-12-31 | ₹66.22 B | -4.38% |
| 2015-12-31 | ₹69.25 B | 215.27% |
| 2014-12-31 | ₹21.96 B | -4.22% |
| 2013-12-31 | ₹22.93 B | 625.75% |
| 2012-12-31 | ₹3.16 B | 2.2% |
| 2011-12-31 | ₹3.09 B | 7.95% |
| 2010-12-31 | ₹2.86 B | -18.62% |
| 2009-12-31 | ₹3.51 B | 18.24% |
| 2008-12-31 | ₹2.97 B | 115.94% |
| 2007-12-31 | ₹1.37 B | -61.05% |
| 2006-12-31 | ₹3.53 B | 31.84% |
| 2005-12-31 | ₹2.68 B | 328.5% |
| 2004-12-31 | ₹0.62 B | 4.9% |
| 2003-12-31 | ₹0.59 B | -57.92% |
| 2002-12-31 | ₹1.41 B | 187.66% |
| 2001-12-31 | ₹0.49 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | ₹1.03 B | -93.17% | 🇺🇸 USA |
 OPKO Health
OPK | ₹69.73 B | 359.07% | 🇺🇸 USA |